Marco Quarta

Company: Rubedo Life Sciences

Job title: Chief Executive Officer & Co-Founder

Seminars:

Multiple Rings to Take Them All: Targeting Cellular Senescence Heterogeneity Across Age-Related Diseases 5:30 pm

Senolytics is a powerful therapeutic opportunity to treat age-related chronic conditions An analogy with cancer cells: Cellular senescence is pleiotropic and characterised by a high degree of heterogeneity Not all states of cellular senescence are relevant therapeutic targets Introducing Alembic: a computational single-cell multi-omics platform developed to elucidate the heterogeneity between cell types and cell…Read more

day: Day One